Search Results - "Faggion, Ivano"

Retinal findings in patients with COVID-19: Results from the SERPICO-19 study by Invernizzi, Alessandro, Torre, Alessandro, Parrulli, Salvatore, Zicarelli, Federico, Schiuma, Marco, Colombo, Valeria, Giacomelli, Andrea, Cigada, Mario, Milazzo, Laura, Ridolfo, Annalisa, Faggion, Ivano, Cordier, Laura, Oldani, Marta, Marini, Sara, Villa, Paolo, Rizzardini, Giuliano, Galli, Massimo, Antinori, Spinello, Staurenghi, Giovanni, Meroni, Luca

“…Coronavirus disease 2019 (COVID-19) has been associated to microvascular alterations. We screened the fundus of patients with COVID-19 to detect alterations of…”
Get full text

Multiple episodes of Plasmodium malariae despite antimalarial treatment: "Quartana te teneat"? by Rizzo, Alberto, Grosso, Silvia, Faggion, Ivano, Gigantiello, Anna, Salari, Federica, Niero, Fosca, Passerini, Simone, Mariani, Chiara, Antinori, Spinello, Gismondo, Maria Rita

“…Asymptomatic infections by P. malariae lasting for several decades have been described in people who had migrated to a malaria-free country or living in…”
Get full text

Drop in plasma lithium levels in 2 patients on concomitant boosted protease inhibitor regimens by Capetti, Amedeo, Landonio, Simona, Faggion, Ivano, Rizzardini, Giuliano

Get full text

Persistent detection and sequencing of SARS‐CoV‐2 in the bloodstream of an immunocompromised patient by Rizzo, Alberto, Foschi, Antonella, Bracchitta, Fiorenza, Faggion, Ivano, Salari, Federica, Borgonovo, Fabio, Fusetti, Chiara, Mileto, Davide, Rizzardini, Giuliano, Lombardi, Alessandra, Gismondo, Maria R., Micheli, Valeria

Get full text

Risk Factors for Hepatotoxicity in Patients Treated With Highly Active Antiretroviral Therapy by Bonfanti, Paolo, Landonio, Simona, Ricci, Elena, Martinelli, Canio, Fortuna, Paolo, Faggion, Ivano, Quirino, Tiziana

Get full text

Incidence of Adverse Reactions in HIV Patients Treated With Protease Inhibitors: A Cohort Study by Bonfanti, Paolo, Valsecchi, Laura, Parazzini, Fabio, Carradori, Silvia, Pusterla, Luigi, Fortuna, Paolo, Timillero, Lia, Alessi, Federica, Ghiselli, Giancarlo, Gabbuti, Andrea, Di Cintio, Elisabetta, Martinelli, Canio, Faggion, Ivano, Landonio, Simona, Quirino, Tiziana

Get full text

Incidence of adverse reactions in HIV patients treated with protease inhibitors : A Cohort Study by BONFANTI, P, VALSECCHI, L, DI CINTIO, E, MARTINELLI, C, FAGGION, I, LANDONIO, S, QUIRINO, T, PARAZZINI, F, CARRADORI, S, PUSTERLA, L, FORTUNA, P, TIMILLERO, L, ALESSI, F, GHISELLI, G, GABBUTI, A

“…To assess the probability that protease inhibitor (PI) therapy might be discontinued because of adverse events (AE) and to evaluate the incidence rate of…”
Get full text

Risk Factors for Hepatotoxicity in Patients Treated With Highly Active Antiretroviral Therapy by Bonfanti, Paolo, Landonio, Simona, Ricci, Elena, Martinelli, Canio, Fortuna, Paolo, Faggion, Ivano, Quirino, Tiziana

Get full text

Risk factors for indinavir-related renal colic in HIV patients: predictive value of indinavir dose/body mass index by MERAVIGLIA, Paola, ANGELI, Elena, DEL SORBO, Francesca, ROMBOLA, Giuseppe, VIGANO, Paolo, ORLANDO, Giovanna, CORDIER, Laura, FAGGION, Ivano, CARGNEL, Antonietta

“…In a prospective study evaluating risk factors for indinavir-related renal colic in 555 HIV-infected patients receiving highly active antiretroviral therapy,…”
Get full text

Risk factors for lipodystrophy in the CISAI cohort by Bonfanti, Paolo, Gulisano, Cecilia, Ricci, Elena, Timillero, Lia, Valsecchi, Laura, Carradori, Silvia, Pusterla, Luigi, Fortuna, Paolo, Miccolis, Sebastiano, Magnani, Carlo, Gabbuti, Andrea, Parazzini, Fabio, Martinelli, Canio, Faggion, Ivano, Landonio, Simona, Quirino, Tiziana, Vigevani, GianMarco

“…Purpose. – This study set out to describe the frequency of lipodystrophy, and identify its risk factors, in HIV-positive patients treated with HAART containing…”
Get full text

Simplification of protease inhibitor-containing regimens with efavirenz, nevirapine or abacavir: safety and efficacy outcomes by CHIESA, Elisabetta, BINI, Teresa, TORDATO, Federica, CICCONI, Paola, CASTELNUOVO, Barbara, RUSCONI, Stefano, D'ARMINIO MONFORTE, Antonella, ADORNI, Fulvio, CAPETTI, Amedeo, RIZZARDINI, Giuliano, FAGGION, Ivano, MUSSINI, Cristina, SOLLIMA, Salvatore, MELZI, Sara, BONGIOVANNI, Marco

“…To describe the immunological and virological outcome, and the factors associated to discontinuation in patients switching to a regimen containing efavirenz…”
Get full text

HAART tolerability: post-exposure prophylaxis in healthcare workers versus treatment in HIV-infected patients by Quirino, T, Niero, F, Ricci, E, Pusterla, L, Carradori, S, Gabbuti, A, Iemoli, E, Landonio, S, Faggion, I, Bonfanti, P

“…The aim of our study is to compare the tolerability of zidovudine/lamivudine/indinavir when used in post-exposure prophylaxis (PEP) subjects and in…”
Get full text

Bilateral carotid stenosis in a young female HIV patient treated with highly active antiretroviral therapy by LANDONIO, Simona, QUIRINO, Tiziana, PELUCCHI, Angelo, MAGNI, Carlo, COEN, Massimo, PORRETTA, Tiziano, FAGGION, Ivano, BONFANTI, Paolo, VIGEVANI, Gian Marco

“…In the past few years, some cases of vascular pathology in HIV-positive patients treated with highly active antiretroviral therapy (HAART) have been reported…”
Get full text

Response to antiretroviral therapy in a patient with an uncommon codon 69 insertion in the human immunodeficiency virus type 1 reverse transcriptase by Bonfanti, P, Faggion, I, La Seta Catamancio, S, Violin, M, Balotta, C, Rusconi, S

Get full text